Medical Condition

inflammatory bowel diseases

Total Trials

14

Recruiting Now

14

Trial Phases

Phase 2, Phase 1, Phase 4

ClinicalMetric tracks all active clinical trials for inflammatory bowel diseases sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — inflammatory bowel diseases Clinical Trials

How many clinical trials are currently recruiting for inflammatory bowel diseases?

ClinicalMetric currently tracks 14 actively recruiting clinical trials for inflammatory bowel diseases, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for inflammatory bowel diseases?

inflammatory bowel diseases research spans Phase 1 (2 trials), Phase 2 (4 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a inflammatory bowel diseases clinical trial?

Eligibility criteria for inflammatory bowel diseases trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 4

Grupo Espanol de Trabajo en En...

View Trial →

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology

inflammatory bowel diseases

Frequently Asked Questions — inflammatory bowel diseases Clinical Trials

Recruiting Clinical Trials

Study of an Environmental Risk Factor in Crohn's Disease

Therapeutic Endpoint in Pediatric IBD Conditions

Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Metformin as Added on Therapy in Patients With Ulcerative Colitis

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Control Crohn Safe Trial

Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance

Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Beta-Hydroxybutyrate Feasibility Treating IBD

Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)